Why the study?
Does PAR-2-activating peptide infusion improve myocardial function and reduce oxidation in a rat model of myocardial ischemia-reperfusion injury?
Population
Rat heart model of experimental myocardial ischemia-reperfusion injury
Design
Preclinical
Authors
Loading...
Hypothesis-generating for PAR-2 activation in myocardial protection; leaves open translation to human therapy.
Does PAR-2-activating peptide infusion improve myocardial function and reduce oxidation in a rat model of myocardial ischemia-reperfusion injury?
PAR-2 activation protects against myocardial ischemia-reperfusion injury in a rat model, highlighting its potential role in modulating the primary inflammatory response to tissue injury.
Napoli et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: